NCT00037011View on ClinicalTrials.gov

Beta-Glucan and Monoclonal Antibody in Treating Patients With Metastatic Neuroblastoma

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

November 30, 2001

Primary Completion Date

January 31, 2005

Conditions
Neuroblastoma
Interventions
BIOLOGICAL

beta-glucan

BIOLOGICAL

monoclonal antibody 3F8

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00037011 - Beta-Glucan and Monoclonal Antibody in Treating Patients With Metastatic Neuroblastoma | Biotech Hunter | Biotech Hunter